This early-stage study is testing whether NT-101 eye drops are safe and might help control wet age-related macular degeneration (AMD), a leading cause of vision loss in older adults. The trial will enroll 30 participants aged 50+ who have active wet AMD in one eye. Researchers wi…
Phase: PHASE1, PHASE2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC